Literature reports suggest that up to 30% of dermatology patients have associated psychiatric co-morbidity. A psychodermatology liaison (PD) clinic is essential to deal with such patients, which is almost non-existent in the Indian scenario. In order to report the working pattern of such a clinic and to determine its efficacy with the help of Dermatology Life Quality Index (DLQI) and Short Assessment of Patient Satisfaction (SAPS) questionnaires, we investigated patients with suspected psychocutaneous diseases in an open-labelled two-year prospective study. Of 236 patients, 86 had psychiatric co-morbidity, 19 had primary psychiatric disorders, 144 were advised psychological interventions and 98 were prescribed psychotropics. A statistically significant fall in DLQI scores at follow-up indicated improvement in quality of life. SAPS scales demonstrated 87.3% of patients in our PD clinic were satisfied with their management in contrast to 53.8% patients in the normal standard dermatology clinic. Nearly 33% of the patients attending our PD clinic had psychiatric co-morbidity, the commonest being an adjustment disorder.
Introduction
Skin and mind have a common ectodermal origin, [1] [2] [3] and stress, hence psychological factors, can trigger or aggravate certain dermatoses. 4, 5 Nearly 30% of dermatology patients have been reported as having associated psychiatric co-morbidity. 6 Psychocutaneous disorders are classified into primary and secondary psychiatric disorders and psychosomatic/psycho-physiologic disorders. 7 The dermatology-psychiatry liaison concept, a multidisciplinary approach for treatment of psycho-dermatologic patients, originated in Europe. [8] [9] [10] The concept of such a liaison clinic is only nascent in India since August 2010. 11 The aims and objectives of the present study were to report the working pattern of our psychodermatology liaison (PD) clinic and to study the extent of psychological or psychiatric co-morbidity among patients attending. We also hoped to determine if our clinic was really useful to patients, by using the Dermatology Life Quality Index (DLQI) and Short Assessment of Patient Satisfaction (SAPS) questionnaires.
DLQI, a simple ten-question validated questionnaire measuring the quality of life, was developed in 1994. 12 The higher the score, the more quality of life is impaired. SAPS consists of seven items that assess the core domains of patient satisfaction with their treatment. 13 
Materials and methods
Ours was an open-labelled prospective study involving patients aged > 18 years, suspected to have psychocutaneous disorders, attending between September 2013 to August 2015. These were referred by a dermatologist and four to five patients were independently evaluated in separate private rooms, unlabelled owing to perceived stigma associated with psychiatry, by a psychiatrist, psychologist and dermatologist. Sessions were run between 14:30 and 17:00. Accompanying relatives were interviewed together with the patient and separately.
Institutional ethics committee clearance was obtained.
Patients were asked to fill a DLQI questionnaire at the beginning and were assessed by dermatologist, clinical psychologist and psychiatrist. The history, clinical findings and treatment advised were noted in a proforma. After three consultations, all patients were classified into either having a psychocutaneous disorder or purely a dermatological disorder. All patients completed the SAPS questionnaire at the end of the first clinical consultation.
At one-month follow-up, dermatological improvement was judged on a scale of À1 to 3 (-1 ¼ worsened, 0 ¼ no change, 1 ¼ mild improvement, 2 ¼ good improvement, 3 ¼ complete clearance). The DLQI was also reassessed.
Prospective controls (age-and sex-matched) who received only dermatologic treatment and who did not attend the PD clinic were asked to fill in the SAPS questionnaire at their first visit.
Findings were analysed using SPSS version 16.0. Tests of significance used were paired t-test and independent sample t-test. Statistical significance was set at a P value <0.05. At the end of the session, all cases were discussed in private. Patients are followed up at regular intervals.
Results
Types and duration of dermatological and psychiatric conditions are noted in Tables 1-3 , and Figure 1 .
Our study had a female preponderance (53.8%), wherein pruritus AE neurotic excoriations, psoriasis, atopic dermatitis and psoriasis predominated. Some 36.44% of our patients had psychiatric co-morbidity. We used psychotropic drugs in 41%. We carried out psychological interventions in 144 (61%) patients, the most common being counselling and psychoeducation, followed by relaxation training, supportive therapy, habit reversal technique, Jacobson's progressive muscle relaxation, distraction techniques, cognitive behavioural therapy and biofeedback. Stress management was also taught. The initial mean DLQI was 11.74 with standard deviation 6.32. Nearly half the patients (42.8%) had a score in the range of 11-20, indicating a very large effect on quality of life.
At follow-up, 97.5% were found to be compliant with drug treatments; however, compliance with psychological interventions was poor. The majority reported improvement of skin disease: mild improvement in 163 patients (69.1%); good to excellent improvement in 38 patients (16.1%); and complete clearance in four patients (1.7%). However, 21 patients (8.9%) reported no improvement and ten patients (4.2%) reported worsening of their conditions. DLQI was repeated at the first follow-up to assess the change in quality of life. The mean one-month follow-up DLQI (FUDLQI) score was 7.31 (SD 5.66). Most, 77 (32.63%), had a score in the range of 2-5 (small effect on quality of life).
Paired t-test was used to compare mean DLQI and FUDLQI scores, which indicated a significant fall (11.74 to 7.31) in the mean DLQI scores at follow-up (P < 0.001).
All patients seen in our PD clinic completed the SAPS whose mean score was 20.46 (SD 2.365). A total of 206 (87.3%) were 'satisfied' with their management but 30 (12.7%) were 'dissatisfied'. None had a score indicating 'very dissatisfied' or 'very satisfied' (Table 4) .
A total of 236 patients attending only the dermatology clinic (117 women with a mean age of 42.2 years) also completed the SAPS questionnaire. Their mean score was 18.37 (SD 2.764). Of these, 127 (53.8%) were 'satisfied' with their management and 109 (46.2%) were 'dissatisfied' (Table 4) .
There was a statistically significant difference in SAPS of the two groups using independent samples ttest (P < 0.001) and 95% confidence interval (CI) 1.63-2.56 indicating a higher satisfaction levels in PD patients compared to the normal dermatology controls.
Discussion
There are only a few published studies on psychodermatology liaison services, chiefly from Israel, 8 Singapore 9 and Germany, 10 and their results are similar to ours. The major disadvantage of psychological interventions was that they were discontinued in the majority, the chief reason being logistics of travel and distance, though patients were usually compliant with oral medication. We presume that our patients attribute lesser importance to non-pharmacological methods and this suggests the need for health education concerning the real benefits of drugs and alternative interventions as adjuvants. This stresses the importance of developing patient-convenient methods such as simple self-administered psychologic interventions which can be effectively taught in one or two visits. Appointing trained psychology assistants in district hospitals and exploring avenues for counsel over the telephone are other options.
The significant fall in mean DLQI scores at followup indicates a considerable improvement in the quality of life suggesting the liaison service is indeed useful.
Our psychodermatology patients showed higher satisfaction levels compared to the standard dermatology patients. This can perhaps be attributed to more time spent with the patient and relatives by various experts, which goes to show that behaviour, attitude and time spent by healthcare workers may have a major impact on patient satisfaction. 
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